Research

The Wilmot Cancer Institute has over 100 dedicated scientists representing 25 academic departments from across the University of Rochester who study cancer biology, the tumor microenvironment, and toxicities and side effects of cancer and its treatment.

Read more about research at Wilmot.

Fellow research is supported with faculty mentors and includes opportunities for clinical research, basic science, qualitative research, and education. Fellows are involved in writing clinical trials with faculty mentors. UR Heme/Onc fellows competitively participate in the ASH Clinical Research Training Institute, the Vail AACR/ASCO Methods in Clinical Cancer Research Workshop, and the FDA-ASCO Hematology and Oncology Fellows Day Workshop.

Fellow research has been recognized both nationally and internationally. Our fellows have been recipients of the ASCO Conquer Cancer Young Investigator Award, the Bennet Travel award, ASCO merit awards, ASH abstract achievement awards, and NIH K -career development awards.

Selected examples of UR Heme/Onc fellows research projects can be found at the links below.

• What Exactly Are We Measuring? Evaluating Sexual and Gender Minority Cultural Humility Training for Oncology Care Clinicians
• Protecting Transgender and Gender-Diverse Patients With Cancer in a Shifting Political Landscape
• Efficacy of Lenalidomide in High-Risk Diffuse Large B-cell Lymphoma
• Pitfalls of Combining Novel Agents in Lymphoma
• Relationships of Self-Perceived Age With Geriatric Assessment Domains in Older Adults With Cancer
• Management of Older Hodgkin Lymphoma Patients
• Elucidating the Associations Between Sleep Disturbance and Depression, Fatigue, and Pain in Older Adults With Cancer
• Early Progression of Follicular Lymphoma: Biology and Treatment
• Allogeneic Hematopoietic Cell Transplantation for Older Adults With Acute Myeloid Leukemia
• Follicular Lymphoma: Redefining Prognosis, Current Treatment Options, and Unmet Needs
• Geriatric Assessment and Treatment Outcomes in Older Adults With Cancer Receiving Immune Checkpoint Inhibitors
• A Case of Burkitt Leukemia: Revisiting the Prognostic Value of Lactate Dehydrogenase
• Social Support for Older Adults With Cancer: Young International Society of Geriatric Oncology Review Paper
• PARP Inhibitors in Older Patients With Ovarian and Breast Cancer: Young International Society of Geriatric Oncology Review Paper
• Management of Melanoma in Patients With Chronic Lymphocytic Leukemia
• Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer
• Toxicities Associated With Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
• Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer
• Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma

Fellows may continue their education by pursuing advanced degrees during their training. The UR offers Masters in Public Health, Masters in Business Administration, and Masters in Clinical Research.